{"schema_version":"secwatch.filing_event.v1","accession":"0001213900-26-034716","form_type":"8-K","ticker":"HIT","cik":"0002019505","company_name":"Health In Tech, Inc.","filed_at":"2026-03-26T23:59:59+00:00","discovered_at":"2026-05-14T18:02:37.003165+00:00","generated_at":"2026-05-15T08:54:47.988605+00:00","sec_items":["1.01","3.02","7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Health In Tech raises $7.0M in PIPE at $1.25 per share","bullets":["Gross proceeds of ~$7.0 million from 5,600,000 shares at $1.25 per share.","Expected close on March 27, 2026; Craig-Hallum Capital Group acted as sole placement agent.","Proceeds to expand sales distribution, advance technology, support new product development, and for working capital.","Resale registration statement to be filed with SEC within 30 days of closing."],"urls":{"canonical":"https://secwatch.observer/filing/0001213900-26-034716","json":"https://secwatch.observer/filing/0001213900-26-034716.json","markdown":"https://secwatch.observer/filing/0001213900-26-034716.md","text":"https://secwatch.observer/filing/0001213900-26-034716.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/2019505/000121390026034716/0001213900-26-034716-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/2019505/000121390026034716/ea0283456-8k_health.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-15T08:54:47.988605+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"4312d378f9ec6e7241ea9f3c404f65316c81ddba","claim":"Health In Tech, Inc. entered into Placement Agency Agreement with Craig-Hallum Capital Group LLC (effective 2026-03-25).","evidence_excerpt":"The Company also entered into a placement agency agreement (the “Placement Agency Agreement”) with Craig-Hallum Capital Group LLC, as the sole placement agent (the “Placement Agent”), dated March 25, 2026, pursuant to which the Placement Agent agreed to serve as the placement agent in connection with the PIPE in consideration for a cash placement fee and the reimbursement of certain out of pocket expenses, including those of its legal counsel.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2019505/000121390026034716/0001213900-26-034716-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"underwriting"},{"label":"Counterparty","value":"Craig-Hallum Capital Group LLC"},{"label":"Effective","value":"2026-03-25"}]},{"claim_id":"5b39fbae2178e07008c453a8af243e548e25c63e","claim":"Health In Tech, Inc. entered into Registration Rights Agreement with each Purchaser (effective 2026-03-25).","evidence_excerpt":"In connection with the Purchase Agreement, the Company entered into a registration rights agreement (the “Registration Rights Agreement”) with each Purchaser.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2019505/000121390026034716/0001213900-26-034716-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Counterparty","value":"each Purchaser"},{"label":"Effective","value":"2026-03-25"}]},{"claim_id":"f3b552132c2223f18b5bd1d27e3ad6ba24dd4250","claim":"Health In Tech, Inc. entered into Purchase Agreement with certain accredited investors valued at approximately $7.0 million (effective 2026-03-25).","evidence_excerpt":"On March 25, 2026, Health In Tech, Inc., a Nevada corporation (the “Company”), announced that it has entered into a securities purchase agreement (the “Purchase Agreement”) with certain accredited investors (each, a “Purchaser” and collectively, the “Purchasers”) relating to a private investment in public equity financing (the “PIPE”) for an aggregate of 5,600,000 shares of its common stock, par value $0.001 per share (the “Shares”).","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/2019505/000121390026034716/0001213900-26-034716-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"certain accredited investors"},{"label":"Value","value":"approximately $7.0 million"},{"label":"Effective","value":"2026-03-25"}]}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}